Natixis’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.05M Buy
6,952
+3,980
+134% +$604K ﹤0.01% 575
2025
Q1
$444K Buy
+2,972
New +$444K ﹤0.01% 648
2024
Q4
Sell
-3,473
Closed -$684K 1052
2024
Q3
$684K Sell
3,473
-268
-7% -$52.8K ﹤0.01% 573
2024
Q2
$773K Sell
3,741
-164
-4% -$33.9K ﹤0.01% 530
2024
Q1
$1.06M Buy
+3,905
New +$1.06M 0.01% 503
2023
Q2
Sell
-4,722
Closed -$953K 1027
2023
Q1
$953K Buy
+4,722
New +$953K 0.01% 522
2022
Q4
Sell
-30,625
Closed -$6.03M 1060
2022
Q3
$6.03M Buy
30,625
+27,800
+984% +$5.47M 0.03% 361
2022
Q2
$605K Sell
2,825
-42,789
-94% -$9.16M ﹤0.01% 863
2022
Q1
$13M Buy
45,614
+30,439
+201% +$8.64M 0.05% 357
2021
Q4
$5.72M Buy
15,175
+2,562
+20% +$965K 0.02% 522
2021
Q3
$5.21M Buy
12,613
+6,633
+111% +$2.74M 0.02% 525
2021
Q2
$2.21M Buy
+5,980
New +$2.21M 0.01% 508
2020
Q2
Sell
-66,200
Closed -$8.36M 751
2020
Q1
$8.36M Sell
66,200
-6,214
-9% -$784K 0.07% 211
2019
Q4
$11M Sell
72,414
-35,450
-33% -$5.38M 0.07% 267
2019
Q3
$14.3M Buy
107,864
+69,281
+180% +$9.17M 0.09% 200
2019
Q2
$5.48M Sell
38,583
-105,076
-73% -$14.9M 0.04% 310
2019
Q1
$20.6M Buy
143,659
+92,692
+182% +$13.3M 0.13% 164
2018
Q4
$5.77M Sell
50,967
-34,721
-41% -$3.93M 0.05% 300
2018
Q3
$11.5M Buy
85,688
+42,666
+99% +$5.74M 0.07% 257
2018
Q2
$4.83M Buy
+43,022
New +$4.83M 0.03% 387
2017
Q4
Sell
-3,132
Closed -$338K 901
2017
Q3
$338K Sell
3,132
-46
-1% -$4.96K ﹤0.01% 849
2017
Q2
$321K Buy
3,178
+95
+3% +$9.6K ﹤0.01% 624
2017
Q1
$277K Buy
+3,083
New +$277K ﹤0.01% 742